Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787800 · ClinicalTrials.gov registry record · Phase 4
The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock
A Phase 4 study of Atrial Fibrillation and Ventricular Tachycardia, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 4
- Study locations
NCT00787800: Completed Phase 4 study of Atrial Fibrillation and Ventricular Tachycardia, sponsored by Mayo Clinic.
NCT00787800 is a Phase 4 study of Atrial Fibrillation and Ventricular Tachycardia that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00787800, a Phase 4 study of Atrial Fibrillation and Ventricular Tachycardia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
The RAPTURE Study will determine whether dual chamber defibrillators with atrial prevention and termination therapies, minimized ventricular pacing, and remote monitoring will reduce the rate of inappropriate shocks and improve quality of life compared to optimally programmed back-up pacing only single chamber ICDs when used for primary prevention of sudden cardiac death
Primary Outcome
An inappropriate shock is defined as a shock delivered by the ICD during a rhythm other than sustained VT/VF (ventricular tachycardia/ventricular fibrillation).
Conditions Studied
Interventions
- DEVICE Dual Chamber ICD
- DEVICE Single Chamber ICD
Study Locations (4)
Other
- Carmel Medical Center - Haifa
- Sheba Medical Center - Ramat Gan
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
What the finished NCT00787800 record still lists
NCT00787800 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Dual Chamber ICD is the first listed.
NCT00787800 reports a single indexed study location in Other, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00787800 about?
NCT00787800 is a clinical study titled "The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock". The RAPTURE Study will determine whether dual chamber defibrillators with atrial prevention and termination therapies, minimized ventricular pacing, and remote monitoring will reduce the rate of inappropriate shocks and improve quality of life compared to optimally programmed back-up pacing only sin...
What is the current status of trial NCT00787800?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2008-11. Estimated completion is 2011-12.
What conditions does trial NCT00787800 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Ventricular Tachycardia, Ventricular Fibrillation, Supraventricular Tachycardia.
What interventions are being tested in trial NCT00787800?
The interventions under investigation include: Dual Chamber ICD (DEVICE), Single Chamber ICD (DEVICE).
Who is sponsoring clinical trial NCT00787800?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00787800 being conducted?
This trial has 4 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00787800's enrollment target sits among peer trials
100 139th of 202 higher than 59 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
RECRUITING · Phase 4
-
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
RECRUITING · Phase 4
-
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
RECRUITING · Phase 4
-
Ondansetron for the Management of Atrial Fibrillation
RECRUITING · Phase 4
-
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
ACTIVE NOT RECRUITING · Phase 4
-
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia